Skip to main content
VCbacked
Log inGet Started

Syros Pharmaceuticals

Watertown, United States

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

$45.0M raised
Dec 2023
Post-IPO Equity
BiotechnologyGeneticsLife SciencePharmaceutical

Top Investors

ARCH Venture PartnersBain CapitalSamsara BioCapitalRedmile GroupBlue Owl

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Syros Pharmaceuticals

How much funding has Syros Pharmaceuticals raised?
Syros Pharmaceuticals has raised $45.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2023.
Who are Syros Pharmaceuticals's investors?
Syros Pharmaceuticals's investors include ARCH Venture Partners, Bain Capital, Samsara BioCapital, Redmile Group, Blue Owl.
Where is Syros Pharmaceuticals headquartered?
Syros Pharmaceuticals is headquartered in Watertown, United States.
What does Syros Pharmaceuticals do?
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
What stage is Syros Pharmaceuticals at?
Syros Pharmaceuticals is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Syros Pharmaceuticals — Funding & Investors." VCBacked, December 19, 2023, https://www.vcbacked.co/company/syros-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2023). Syros Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/syros-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Syros Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/syros-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K